DENDREON CORPORATION Inactive Instrument
Company Dendreon Corporation Nasdaq
Equities
US24823Q1076
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
| 2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 158,716,893 | 153,327,147 ( 96.60 %) | 0 | 96.60 % |
Company contact information
Dendreon Corp.
1208 Eastlake Avenue East
98102, Seattle
+206-256-4545
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -1.82% | 41.36B | |
| +44.25% | 41.3B | |
| +2.56% | 39.61B | |
| -12.11% | 25.62B | |
| +3.09% | 24.09B | |
| -24.16% | 18.38B | |
| +22.12% | 11.85B | |
| -3.74% | 11.82B | |
| +7.75% | 11.07B |
- Stock Market
- Equities
- Stock
- Stock
- Company Dendreon Corporation
